Claire E. Kim

Dr. Claire E. Kim

Epidemiology, Harvard University, Cambridge, Maryland, USA
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2018 in BMC Public Health
Verified
Journal Article
Open access
PDF file
CKClaire E. Kim
Claire E. Kim
SSSangah Shin
Sangah Shin
HLHwi-Won Lee
Hwi-Won Lee
JLJiyeon Lim
Jiyeon Lim
JLJong-koo Lee
Jong-koo Lee
Daehee KangDaehee Kang
Daehee Kang
Both short and long sleep duration have been consistently studied as a risk factor for obesity, hyperglycemia and hypertension. In this cross-sectional study, we provide an updated analysis of the Health Examinees (HEXA) study on the association between sleep duration and metabolic syndrome (MetS) occurrence among Koreans age 40–69 year olds. A total of 133,608 subjects (44,930 men, 88,678 women) were enrolled in the HEXA study 2004–2013. Sleep duration was categorized into 4 sleep categories (< 6 h, 6 to < 8 h, 8 to < 10 h, ≥10 h). MetS criterion was based on the National Cholesterol Education Program, Adult Treatment Panel III. Logistic regression was used to calculate adjusted odds ratios (ORs) and 95% confidence intervals (CIs). Compared with individuals sleeping 6 to < 8 h per day, less than 6 h of sleep was associated with MetS (multivariable adjusted OR: 1.12, 95% CI: 1.05–1.19) and elevated waist circumference (1.15, 1.08–1.23) among men; with elevated waist circumference (1.09, 1.04–1.14) among women. Greater than 10 h of sleep was associated with MetS (1.28, 1.08–1.50) and elevated triglycerides (1.33, 1.14–1.56) among men; with MetS (1.40, 1.24–1.58), elevated waist circumference (1.14, 1.02–1.27), elevated triglycerides (1.41, 1.25–1.58), reduced high-density lipoprotein cholesterol (HDL-C) (1.24, 1.12–1.38), and elevated fasting glucose (1.39, 1.23–1.57) among women. Less than 6 h of sleep is associated with elevated waist circumference among both men and women and with MetS among men only. Greater than 10 h of sleep is associated with MetS and elevated triglycerides among both men and women and with elevated waist circumference, reduced HDL-C, and elevated fasting glucose among women only.

2 July 2017 in Nutrients
Verified
Journal Article
Open access
PDF file
SSSangah Shin
Sangah Shin
HLHwi-Won Lee
Hwi-Won Lee
CKClaire E. Kim
Claire E. Kim
JLJiyeon Lim
Jiyeon Lim
JLJong-koo Lee
Jong-koo Lee
Daehee KangDaehee Kang
Daehee Kang
Metabolic syndrome (MetS) is defined as a cluster of metabolic alterations such as abdominal obesity, dyslipidemias, elevated fasting glucose, and hypertension. Studies on the association between egg consumption and MetS are limited and inconsistent. A cross-sectional analysis was conducted to examine the association of egg consumption with MetS among Korean adults aged 40–69 years. A total of 130,420 subjects (43,682 men and 86,738 women) from the Health Examinees Study were selected for the final analysis. Egg consumption was estimated using a validated 106-item food frequency questionnaire. MetS was defined using the National Cholesterol Education Program, Adult Treatment Panel III. Logistic regression analyses were performed to identify the association of egg consumption with MetS via odds ratios (ORs) and 95% confidence intervals (CIs) after adjusting for potential variables. Among 130,420 subjects, 34,039 (26.1%) people had MetS. Consumption of more than 7 eggs/week was associated with a lower odds of MetS risk compared to those who consumed less than one egg/week in women (OR: 0.77, 95%CI: 0.70–0.84, p trend < 0.0001). Higher egg consumption was inversely associated with the MetS components: elevated waist circumference (OR: 0.80, 0.75–0.86), elevated triglyceride (OR: 0.78, 0.72–0.85), reduced high-density lipoprotein cholesterol (HDL-C) (OR: 0.82, 0.77–0.88), elevated blood pressure (OR: 0.86, 0.80–0.92), and elevated fasting glucose (OR: 0.94, 0.83–0.99) in women; reduced HDL-C (OR: 0.89, 0.80–1.00) in men. Our results suggest that higher egg consumption may be associated with a reduction in the odds for MetS and all five metabolic components in women, and the risk of reduced HDL-C in men.

8 October 2017 in Nutrients
Verified
Journal Article
Open access
PDF file
SSSangah Shin
Sangah Shin
HLHwi-Won Lee
Hwi-Won Lee
CKClaire E. Kim
Claire E. Kim
JLJiyeon Lim
Jiyeon Lim
JLJong-koo Lee
Jong-koo Lee
Daehee KangDaehee Kang
Daehee Kang
It has been suggested that a greater dairy consumption, particularly of milk, may have contributed in lowering the prevalence of metabolic syndrome (MetS). A cross-sectional analysis was conducted to examine the association between milk consumption and MetS, and its components among Korean adults aged 40–69. A total of 130,420 subjects (43,682 men and 86,738 women) from the Health Examinees Study were selected for the final analysis. Milk consumption was estimated using a validated 106-item food frequency questionnaire. MetS was defined using the National Cholesterol Education Program, Adult Treatment Panel III (NCEP III). Logistic regression analyses were performed to calculate the odds ratios (ORs) and 95% confidence intervals (CIs) between milk consumption and MetS after adjusting for potential confounders. In this study, the average milk consumption was 77.9 g/day, with the overall prevalence of MetS being 26.1% (29.1% in men and 24.6% in women). We found that the prevalence of the MetS was significantly lower in subjects with higher milk consumption (p < 0.0001). Adjusted OR for MetS was significantly lower in the highest milk consumption category (≥1 serving/day among men; ≥2 serving/day among women) than those in the lowest milk consumption category (OR: 0.92 95%CI: 0.86–0.99, p trend = 0.0160 in men; OR: 0.68, 95%CI: 0.60–0.76, p trend < 0.0001 in women). Overall, higher milk consumption was inversely associated with the MetS components: elevated waist circumference, elevated triglyceride, and reduced high-density lipoprotein cholesterol (HDL-C) (all p trend < 0.05). This study concludes that higher milk consumption is associated with the lower odds of MetS in Korean adults.

21 November 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
CKClaire E. Kim
Claire E. Kim
LYLara Yoon
Lara Yoon
KMKarin B. Michels
Karin B. Michels
WTWynn Tranfield
Wynn Tranfield
Jonathan JacobsJonathan Jacobs
Jonathan Jacobs
FMFolasade P. May
Folasade P. May
Prebiotic and probiotic supplementation and yogurt consumption (a probiotic food) alter gut microbial diversity, which may influence colorectal carcinogenesis. This systematic review evaluates the existing literature on the effect of these nutritional supplements and yogurt consumption on colorectal neoplasia incidence among adults. We systematically identified ten randomized controlled trials and observational studies in adults age ≥ 18 without baseline gastrointestinal disease. Prebiotics included inulin, fructooligosaccharides, galactooligosaccharides, xylooligosaccharides, isomaltooligosaccharides, and β-glucans. Probiotics included bacterial strains of Lactobacillus, Bifidobacterium, Saccharomyces, Streptococcus, Enterococcus, Bacillus, Pediococcus, Leuconostoc, and Escherichia coli. Synbiotic supplements, a mixture of both prebiotic and probiotic supplements, and yogurt, a commonly consumed dietary source of live microbes, were also included. We defined colorectal neoplasia as colorectal adenomas, sessile serrated polyps, and colorectal cancer (CRC). Overall, findings suggest a moderate decrease in risk of adenoma and CRC for high levels of yogurt consumption compared to low or no consumption. Prebiotic supplementation was not associated with colorectal neoplasia risk. There was some evidence that probiotic supplementation may be associated with lower risk of adenomas but not with CRC incidence. Higher yogurt consumption may be associated with lower incidence of colorectal neoplasia. We found little evidence to suggest that prebiotic or probiotic supplements are associated with significant decreases in CRC occurrence.

1 January 2018 in Nutrition Research and Practice
Verified
Journal Article
Open access
PDF file
JLJiyeon Lim
Jiyeon Lim
YLYunhee Lee
Yunhee Lee
SSSangah Shin
Sangah Shin
HLHwi-Won Lee
Hwi-Won Lee
CKClaire E. Kim
Claire E. Kim
Daehee KangDaehee Kang
Daehee Kang
Lim J, et al. Nutr Res Pract. 2018 Jun;12(3):258-264. https://doi.org/10.4162/nrp.2018.12.3.258

CKClaire E. Kim
Claire E. Kim
SSSangah Shin
Sangah Shin
HLHwi-Won Lee
Hwi-Won Lee
JLJiyeon Lim
Jiyeon Lim
JLJong-koo Lee
Jong-koo Lee
Daehee KangDaehee Kang
Daehee Kang
Studies regarding the association between snoring and metabolic abnormalities have been inconsistent. We examine whether snoring frequency and obstructive sleep apnea markers are associated with metabolic syndrome (MetS) among Koreans aged 40–69 years. A total of 72,885 subjects (24,856 men, 48,029 women) from the Health Examinees Gem study between 2009 and 2013 were included. Snoring frequency was grouped into five categories (never, 1–3/month, 1–3/week, 4–5/week, 6+/week). Obstructive sleep apnea markers included breathing interruptions and awakenings. Adjusted odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated through logistic regression. Compared with non-snorers, those who snore 6+/week were associated with increased odds for MetS (OR: 2.07, 95% CI: 1.91–2.25, p-trend < 0.0001 among men; OR: 1.45, CI: 1.33–1.58, p-trend < 0.0001 among women). Snoring frequency is associated with MetS and its components in both men and women. Snoring and obstructive sleep apnea markers are important indicators of sleep quality, which may facilitate early detection of sleep disorders and further complications such as MetS.